CBAK Energy Agrees on Battery Supply Framework with European Customer

CBAK Energy projects $30 million annual sales to a European customer by 2027, but only $4.5 million is realised.

What the company is saying

CBAK Energy is announcing a supply framework agreement with an unnamed European blue-chip technology company, emphasizing its battery technology, manufacturing experience, and ability to meet performance and quality requirements as reasons for selection. The company highlights that cumulative orders from this customer exceeded $4.5 million as of September 27, 2026, and projects annual sales from current business with this customer to surpass $30 million in both 2027 and 2028. Management, led by CEO Zhiguang Hu, frames the announcement as evidence of growing momentum, stating that initial supply has begun and sales are expected to increase. The company also stresses its ongoing development of a higher-capacity cell, with commercial deliveries expected to start in 2027, and claims this product could lead to larger orders and a long-term relationship. Sales projections for 2027 and 2028 explicitly exclude the new cell, which is positioned as a future growth driver. The identity of the European customer is withheld by mutual agreement, and the company’s tone is confident but forward-looking.

What the data suggests

The only realised figure is $4.5 million in cumulative orders from the European customer as of September 27, 2026. The company expects annual sales from current business with this customer to exceed $30 million in both 2027 and 2028, but these are projections, not binding commitments. No purchase orders for the near-term business have been received, and actual sales will depend on future orders, pricing, deliveries, and customer acceptance. The new higher-capacity cell is still under development, with commercial deliveries targeted for 2027, and sales from this product are not included in the $30 million annual estimates. The company claims few comparable products exist for the new cell but provides no market data or third-party validation. There is no disclosure of broader company revenue, profitability, or cash flow, so the overall financial impact remains unclear. The evidence supports a modest realised business and a much larger, but unproven, projected ramp-up.

Analysis

The announcement presents a positive tone, highlighting a supply framework with a European blue-chip customer and projecting significant sales growth. However, only $4.5 million in cumulative orders are realised as of September 27, 2026, while the much larger $30 million annual sales figures for 2027 and 2028 are forward-looking projections, not yet realised or contractually guaranteed. The development of a new, higher-capacity cell is also future-dated, with commercial deliveries expected in 2027 and no sales from this product included in the current projections. There is no disclosure of profitability, margins, or broader financials, limiting the ability to assess the sustainability or value of the growth. The language around market leadership and long-term supply relationships is aspirational and unsupported by evidence. The gap between narrative and evidence is moderate: realised business is modest, while the bulk of the announcement's value is projected and unproven.

Risk flags

• ●The $30 million annual sales projections for 2027 and 2028 are not backed by binding purchase commitments; actual orders have not been received, so there is significant execution risk if the customer delays, reduces, or cancels orders.
• ●Sales of the new higher-capacity cell, positioned as a future growth driver, are not included in current projections and depend on successful development, qualification, and customer acceptance, any of which could be delayed or fail.
• ●The identity of the European customer is confidential, limiting external validation of the deal’s scale, credibility, and durability, and increasing counterparty concentration risk.
• ●The company provides no information on profitability, margins, or broader financials, so the impact of these sales on overall financial health and sustainability cannot be assessed.
• ●Forward-looking statements rely on assumptions about customer demand, pricing, and supply chain stability, all of which are subject to change and could materially affect outcomes.

Bottom line

CBAK Energy’s announcement signals a potentially transformative customer relationship, with only $4.5 million in cumulative orders realised so far and much larger sales—over $30 million per year—projected for 2027 and 2028. These projections are not underpinned by binding commitments, and actual sales will depend on future customer orders and successful product qualification. The new higher-capacity cell, which could further increase order size, is still under development and will not contribute to sales until at least 2027. The lack of detail on profitability, margins, and total company revenue means investors cannot assess the true financial impact. The most important takeaway is that while the framework agreement and initial orders are real, the bulk of the value remains speculative and subject to execution risk. Investors should focus on whether large purchase orders materialise and whether the new product launches on schedule.

Announcement summary

(NASDAQ:CBAT) CBAK Energy Technology Limited announced it has agreed on a battery supply framework with a European blue-chip technology company serving automotive and industrial markets worldwide. The European Customer selected CBAK Energy for its battery technology, manufacturing experience, and ability to meet performance and quality requirements. As of September 27, 2026, cumulative orders from the European Customer had exceeded US $4.5 million. CBAK Energy expects the total value of orders to continue to grow. The company expects annual sales from its current business with the European Customer to exceed US $30 million in each of 2027 and 2028. The cooperation includes the development of a new, higher-capacity cell, with commercial deliveries expected to begin in 2027. Sales of this new cell are not included in the annual sales estimates for 2027 and 2028. CBAK Energy believes there are currently few comparable products on the market and expects the new cell to lead to larger orders and a long-term supply relationship. Zhiguang Hu, Chief Executive Officer of CBAK Energy, stated that the framework is in place, initial supply has begun, and sales are expected to increase in the coming years. The company attributes its success in winning the business to its technology and manufacturing experience. CBAK Energy does not name the European Customer, citing mutual agreement. The company develops, manufactures, and sells high-power lithium-ion and sodium-ion batteries, as well as materials used in high-power lithium-ion batteries. Its operations include battery cell production, research and development, and sales in Nanjing, Dalian, and Shangqiu, with R&D centers in Nanjing and Dalian, and a raw materials business in Shaoxing. CBAK Energy's products serve electric vehicles, light electric vehicles, energy storage systems, and other high-power applications. In January 2006, CBAK Energy became the first Chinese lithium battery manufacturer to be listed on the Nasdaq Stock Market.

Disagree with this article?